New prosthetic control strategy could give amputees a better grip on daily life

NCT ID NCT06539936

Recruiting now Symptom relief Sponsor: Infinite Biomedical Technologies Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares a new myoelectric control strategy called Glide to the standard Direct Control method for upper limb prostheses. Seven adults with below-elbow amputations will use both systems over 24 weeks to see which offers better function, satisfaction, and ease of use. The goal is to determine if Glide helps users perform daily tasks more effectively.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Glide myoelectric prosthesis control strategy (device)
What this could lead to: If successful, this could provide amputees with a more intuitive and effective way to control their prosthetic hand, improving daily function and satisfaction.
What could go wrong: This is a very small early-stage trial with only 7 participants, so results may not apply to everyone. The new control strategy might not prove better than the standard approach.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMPUTATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AMPUTATION UPPER LIMB

Contacts and locations

Locations

Advanced Arm Dynamics
RECRUITING

Redondo Beach, California, 90277, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.